Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Businessweek Archives

From Chemical Soup, Drugs That Go Down The Hatch


Developments to Watch

FROM CHEMICAL SOUP, DRUGS THAT GO DOWN THE HATCH

In the 1960s, scientists conducted experiments to see if they could recreate the origins of life. By applying voltage to a soup of chemicals, they managed to produce amino acids and proteins, the building blocks of life. Eventually, the experiments yielded tiny, hollow spheres made from protein-like materials.

Now, nearly 30 years later, Clinical Technologies Associates Inc. in Elmsford, N. Y., is using similar microspheres to make oral forms of drugs, such as insulin, heparin, and other "large molecules" that now must be injected. These drugs can't be taken orally because they are broken down in the digestive tract before they can get into the bloodstream. But CTA's microspheres absorb the large molecules when both are put into an acidic solution. This coating protects the drugs as they travel through the gut. Once in the bloodstream, the microspheres dissolve, releasing the drug. So far, CTA has licensed the technology to Upjohn Co. and Genetics Institute, a biotech company.EDITED BY NAOMI FREUNDLICH


The Aging of Abercrombie & Fitch
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus